Nexium class includes members who haven't been injured, AstraZeneca tells court
The inclusion of uninjured class members requires that the class certification be overturned in litigation alleging an illegal agreement to delay generic Nexium, counsel for AstraZeneca told a federal appeals court on...To view the full article, register now.
Already a subscriber? Click here to view full article